Lorne F Erdile

Title: Lorne F Erdile: Innovator in Medical Technology

Introduction

Lorne F Erdile is a notable inventor based in Loudonville, NY (US). He has made significant contributions to the field of medical technology, particularly in the areas of cryopreservation and the treatment of atherosclerosis.

Latest Patents

Erdile holds 2 patents that showcase his innovative approaches. His first patent focuses on the "Cryopreservation of haptenized tumor cells." This method involves using a freezing medium that contains an effective amount of sucrose and human serum albumin in an isotonic buffered saline solution. The process has been shown to maintain the integrity of tumor cells during storage, allowing them to retain cell-associated antigens and haptens, making them as immunogenic as fresh vaccines in a mouse model of metastatic disease. The second patent addresses "Restenosis/atherosclerosis diagnosis, prophylaxis and therapy." This patent discloses compositions and methods for the therapy and prevention of these conditions, including agents that decrease the viral load of cytomegalovirus (CMV). The methods also encompass diagnosing atherosclerosis and restenosis through various screening techniques.

Career Highlights

Throughout his career, Erdile has focused on developing innovative solutions that address critical health issues. His work has the potential to significantly impact the fields of immunotherapy and cardiovascular health.

Collaborations

Erdile has collaborated with notable professionals in his field, including David Berd and Margalit B Mokyr. These partnerships have likely contributed to the advancement of his research and innovations.

Conclusion

Lorne F Erdile is a distinguished inventor whose work in medical technology continues to pave the way for advancements in treatment and diagnosis. His patents reflect a commitment to improving patient outcomes through innovative solutions.